Related Experiment Video
Updated: Jun 24, 2026

Subcutaneous Infection of Methicillin Resistant Staphylococcus Aureus (MRSA)
Published on: February 9, 2011
Daptomycin therapy failure in an adolescent with methicillin-resistant Staphylococcus aureus bacteremia
Lara M Jacobson1, Aaron M Milstone, Jonathan Zenilman
1Department of Pediatrics, Johns Hopkins University School of Medicine, Baltimore, MD, USA. ljacob19@jhmi.edu
Abstract:
Daptomycin is a Food and Drug Administration-approved alternative to vancomycin for the treatment of serious methicillin-resistant Staphylococcus aureus infections in adults. Treatment failure with daptomycin is increasingly reported in adults, but data in children are limited. We report an adolescent patient with severe burn injuries who had persistent methicillin-resistant Staphylococcus aureus bacteremia and rapidly developed nonsusceptibility to daptomycin. We review the relevant literature.
Related Concept Videos
Clinical Significance of Antibiotic Resistance
Mechanism of Antibiotic Resistance in MRSA
Staphylococcal Skin Infections
Rocky Mountain Spotted Fever
Acute Pyelonephritis II: Diagnostic Studies and Management
Inhibitors of Bacterial Protein Synthesis